Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1733 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Ipsen Total Revenues Up 7% In 2009

Ipsen has posted a net income of EUR157.16m, an increase of 6.9%, compared to EUR147.07m. Total revenues were EUR1.11bn, an increase of 7.2%, compared to EUR1.04bn for the